Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 63

Sort by

Sort Order Select

Journal Articles

Allogeneic Chimeric Antigen Receptor-Invariant Natural Killer T Cells Exert Both Direct and Indirect Antitumor Effects through Host CD8 T Cell Cross-Priming

Federico Simonetta, MD PhD, Toshihito Hirai, MD PhD, Juliane K. Lohmeyer, MD, Kristina Maas-Bauer, MD, Maite Alvarez, PhD, Arielle S. Wenokur, Jeanette Baker, Amin Aalipour, PhD, Samuel Haile, PhD, Crystal L. Mackall, MD, Robert S. Negrin, MD

Blood (2019) 134 (Supplement_1): 867.

https://doi.org/10.1182/blood-2019-122515

Published: 2019

Journal Articles

Eomes and IL-10 Regulate Anti-Tumor Activity of T Cells in Chronic Lymphocytic Leukemia

Laura Llaó Cid, M.Sc, Philipp M Rößner, MD, Ekaterina Lupar, PhD, Bola S Hanna, PhD, Jérôme Paggetti, PhD, Etienne Moussay, PhD, Dolors Colomer, PhD, Sascha Dietrich, MD, Stephan Stilgenbauer, MD, Ana Izcue, PhD, Martina Seiffert, PhD

Blood (2019) 134 (Supplement_1): 4288.

https://doi.org/10.1182/blood-2019-128465

Published: 2019

Journal Articles

Evaluation of the Prognostic Significance and Effect of NT5E-Adenosine Axis, a Novel Immune Checkpoint, in Diffuse Large B-Cell Lymphoma

Xianhuo Wang, Tingting Zhang, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Bin Meng, Xiubao Ren, Huilai Zhang, Kai Fu, MD PhD

Blood (2019) 134 (Supplement_1): 2801.

https://doi.org/10.1182/blood-2019-124233

Published: 2019

Journal Articles

Galectin-9 from Bone Marrow Mesenchymal Stromal Cells Mediates Immunosuppression on Chimeric Antigen Receptor T Cells

Xinyi Teng, BS, Hao Zhang, MD, Zuyu Liang, MD, Mi Shao, MD, Xiujian Wang, MD, Lijuan Ding, MD, Jiazhen Cui, msc, Yongxian Hu, MD, He Huang, MD PhD

Blood (2019) 134 (Supplement_1): 5609.

https://doi.org/10.1182/blood-2019-131680

Published: 2019

Journal Articles

Co-Prevalence of Pre-Existing Immunity to Different Serotypes of Adeno-Associated Virus (AAV) in Adults with Hemophilia

Kavitha Rajavel, Mila Ayash-Rashkovsky, Ying Tang, Bagirath Gangadharan, Maurus de la Rosa, Bruce Ewenstein

Blood (2019) 134 (Supplement_1): 3349.

https://doi.org/10.1182/blood-2019-123666

Published: 2019

Journal Articles

Frequent STAT3 Mutations in CD8 + T Cells from Patients with Pure Red Cell Aplasia

Toru Kawakami, MD, Nodoka Sekiguchi, MD PhD, Jun Kobayashi, Tatsuya Imi, MD, Kazuyuki Matsuda, PhD, Taku Yamane, Sayaka Nishina, MD, Yasushi Senoo, MD, Hitoshi Sakai, MD PhD, Toshiro Ito, MD PhD, Tomonobu Koizumi, MD PhD, Makoto Hirokawa, MD PhD, Shinji Nakao, MD PhD, Hideyuki Nakazawa, PhD MD, Fumihiro Ishida, MD FACP

Blood (2018) 132 (Supplement 1): 536.

https://doi.org/10.1182/blood-2018-99-112132

Published: 2018

Journal Articles

Gene Set Enrichment Analysis Suggests That Increased Rituximab-Mediated NK Cell Cytotoxicity after Vitamin D Substitution Is Driven By Upregulation of Interferon Alpha (IFN-a) Isoforms

Konstantinos Christofyllakis, MD, Frank Neumann, PhD, Stephan Stilgenbauer, Dominic Kaddu-Mulindwa, MD, Evi Regitz, Moritz Bewarder, MD, Andreas Keller, PhD MSc, Jörg Thomas Bittenbring, MD

Blood (2018) 132 (Supplement 1): 3696.

https://doi.org/10.1182/blood-2018-99-111817

Published: 2018

Journal Articles

An International Epidemiology Study to Determine the Prevalence of Preexisting Cell-Mediated Immunity to Adeno-Associated Virus (AAV) in Adults with Severe Hemophilia

Kavitha S. Rajavel, PhD, John C. Chapin, MD, Ying Tang

Blood (2018) 132 (Supplement 1): 5794.

https://doi.org/10.1182/blood-2018-99-113308

Published: 2018

Journal Articles

Modulation of T-Cell Function in the Microenvironment of Emu-TCL1 CLL Bearing Mice By Btki Appears Independent of ITK

Mark-Alexander Schwarzbich, MD, Arantxa Romero-Toledo, MSc, Melanie Frigault, PhD, John G. Gribben

Blood (2018) 132 (Supplement 1): 3139.

https://doi.org/10.1182/blood-2018-99-116444

Published: 2018

Journal Articles

Clinical Significance of PD-1 and PD-L1 Expression and Ongoing Interaction in the Tumor Microenvironment in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

Blood (2017) 130 (Supplement 1): 197.

https://doi.org/10.1182/blood.V130.Suppl_1.197.197

Published: 2017

Journal Articles

CD200 Is a Potent New Growth Factor in Multiple Myeloma through IGF-1R Interaction

Angélique Bruyer, MSc, Nicolas Robert, Stéphanie Boireau, Christophe Hirtz, Laurent Tiers, Laure Vincent, Guillaume Cartron, Dirk Hose, MD, Anja Seckinger, Bernard Klein, PhD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 3045.

https://doi.org/10.1182/blood.V130.Suppl_1.3045.3045

Published: 2017

Journal Articles

PD-1 Blockade after Epigenetic Therapy in Patients with Relapsed or Refractory Hodgkin Lymphoma: Higher-Than-Expected Rate of Complete Responses

Lorenzo Falchi, MD, Ahmed Sawas, MD, Changchun Deng, MD PhD, Jennifer E Amengual, MD, Emily Lichtenstein, RN, Karen Khan, BSN, Lawrence H. Schwartz, MD, Owen A. O'Connor, MD PhD

Blood (2016) 128 (22): 2999.

https://doi.org/10.1182/blood.V128.22.2999.2999

Published: 2016

Journal Articles

Increased Prevalence of t(8;9)(p21-23;p23-24) Translocations within 9p24 Abnormalities in Patients with Myeloid Malignancies Identified from the Mitelman Database

Matthew K Stein, MD, Dilan Patel, MD, Andrew Hahn, MD, Jamie Riney, MD, Michael G. Martin, MD

Blood (2016) 128 (22): 1935.

https://doi.org/10.1182/blood.V128.22.1935.1935

Published: 2016

Journal Articles

Human CD8 + Treg after Allogeneic Stem-Cell Transplantation

Tobias A.W. Holderried, MD, Pia Sauerborn, Hye-Jung Kim, PhD, Harvey Cantor, MD, Dominik Wolf, MD, Peter Brossart, MD

Blood (2016) 128 (22): 2243.

https://doi.org/10.1182/blood.V128.22.2243.2243

Published: 2016

Journal Articles

Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy to Prevent Viral Reactivation in Recipients of Allogeneic T Cell Depleted Stem Cell Transplant

Pawel Muranski, MD, Greg Whitehill, BS, Debbie Draper, RN, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Quan Yu, MS, Marianna Sabatino, MD, Steven L. Highfill, PhD, Hanh Khuu, MD, Sarah I Davies, Mark Chang, Upneet Chawla, BS, MD, Alexandros Spyridonidis, MD PhD, Gary Fahle, MT,SM, Sawa Ito, MD PhD, David Stroncek, MD, Minoo Battiwalla, MDMS, John Barrett, MD

Blood (2016) 128 (22): 979.

https://doi.org/10.1182/blood.V128.22.979.979

Published: 2016

Journal Articles

Tumorantigen-Specific CD40B Cells: Combining Enhanced Antigen-Presentation and Antibody-Secretion for Tumor Targeting

Kerstin Wennhold, PhD, Martin Thelen, Maria gracia Marquez, Christof Scheid, MD PhD, Alexander Shimabukuro-Vornhagen, MD, Michael von Bergwelt-Baildon, Prof. Dr. Dr.

Blood (2015) 126 (23): 1030.

https://doi.org/10.1182/blood.V126.23.1030.1030

Published: 2015

Journal Articles

Transfused Stored or Antibody-Coated Red Blood Cells Are Internalized By and Activate Splenic Professional Antigen Presenting Cells

Stuart Phillip Weisberg, MD PhD, Lyla A Youssef, Sheila Bandyopadhyay, BA, Richard O. Francis, MDPhD, James C. Zimring, MD PhD, Eldad A. Hod, MD

Blood (2015) 126 (23): 3564.

https://doi.org/10.1182/blood.V126.23.3564.3564

Published: 2015

Journal Articles

Updated Results of a Phase 1/2a, Dose Escalation Study of Pvx-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)

Ajay K. Nooka, MD MPH, Michael Wang, MD, Andrew J. Yee, MD, Sheeba K. Thomas, MD, Elizabeth K. O'Donnell, MD, Jatin J. Shah, MD, Jonathan L. Kaufman, MD, Sagar Lonial, MD, Paul G. Richardson, MD, Noopur S. Raje, MD

Blood (2015) 126 (23): 4246.

https://doi.org/10.1182/blood.V126.23.4246.4246

Published: 2015

Journal Articles

Intermediate Filament (IF) Protein Vimentin Regulates T Cell Mediated Immune Response in Gvhd

Dan Li, PhD, Patenia Rebecca, BS, Miguel A. Cruz, PhD, Jeffrey J. Molldrem, MD, Richard E. Champlin, MD, Qing Ma, PhD

Blood (2015) 126 (23): 3073.

https://doi.org/10.1182/blood.V126.23.3073.3073

Published: 2015

Journal Articles

Initial Results of a Phase 1/2a, Dose Escalation Study of PVX-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)

Michael (Luhua) Wang, MD, Ajay K. Nooka, MD MPH, Andrew J. Yee, MD, Sheeba K. Thomas, MD, Elizabeth O'Donnell, MD, Jatin Shah, MD, Donna M. Weber, MD, Jonathan L. Kaufman, MD, Sagar Lonial, MD, David Avigan, MD, Noopur Raje, MD

Blood (2014) 124 (21): 4737.

https://doi.org/10.1182/blood.V124.21.4737.4737

Published: 2014

NARROW

Allogeneic Chimeric Antigen Receptor-Invariant Natural Killer T Cells Exert Both Direct and Indirect Antitumor Effects through Host CD8 T Cell Cross-Priming

Eomes and IL-10 Regulate Anti-Tumor Activity of T Cells in Chronic Lymphocytic Leukemia

Evaluation of the Prognostic Significance and Effect of NT5E-Adenosine Axis, a Novel Immune Checkpoint, in Diffuse Large B-Cell Lymphoma

Galectin-9 from Bone Marrow Mesenchymal Stromal Cells Mediates Immunosuppression on Chimeric Antigen Receptor T Cells

Co-Prevalence of Pre-Existing Immunity to Different Serotypes of Adeno-Associated Virus (AAV) in Adults with Hemophilia

Frequent STAT3 Mutations in CD8 + T Cells from Patients with Pure Red Cell Aplasia

Gene Set Enrichment Analysis Suggests That Increased Rituximab-Mediated NK Cell Cytotoxicity after Vitamin D Substitution Is Driven By Upregulation of Interferon Alpha (IFN-a) Isoforms

An International Epidemiology Study to Determine the Prevalence of Preexisting Cell-Mediated Immunity to Adeno-Associated Virus (AAV) in Adults with Severe Hemophilia

Modulation of T-Cell Function in the Microenvironment of Emu-TCL1 CLL Bearing Mice By Btki Appears Independent of ITK

Clinical Significance of PD-1 and PD-L1 Expression and Ongoing Interaction in the Tumor Microenvironment in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

CD200 Is a Potent New Growth Factor in Multiple Myeloma through IGF-1R Interaction

PD-1 Blockade after Epigenetic Therapy in Patients with Relapsed or Refractory Hodgkin Lymphoma: Higher-Than-Expected Rate of Complete Responses

Increased Prevalence of t(8;9)(p21-23;p23-24) Translocations within 9p24 Abnormalities in Patients with Myeloid Malignancies Identified from the Mitelman Database

Human CD8 + Treg after Allogeneic Stem-Cell Transplantation

Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy to Prevent Viral Reactivation in Recipients of Allogeneic T Cell Depleted Stem Cell Transplant

Tumorantigen-Specific CD40B Cells: Combining Enhanced Antigen-Presentation and Antibody-Secretion for Tumor Targeting

Transfused Stored or Antibody-Coated Red Blood Cells Are Internalized By and Activate Splenic Professional Antigen Presenting Cells

Updated Results of a Phase 1/2a, Dose Escalation Study of Pvx-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)

Intermediate Filament (IF) Protein Vimentin Regulates T Cell Mediated Immune Response in Gvhd

Initial Results of a Phase 1/2a, Dose Escalation Study of PVX-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only